BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 16455766)

  • 1. Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression.
    Fareed MU; Evenson AR; Wei W; Menconi M; Poylin V; Petkova V; Pignol B; Hasselgren PO
    Am J Physiol Regul Integr Comp Physiol; 2006 Jun; 290(6):R1589-97. PubMed ID: 16455766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NF-kappaB inhibitor curcumin blocks sepsis-induced muscle proteolysis.
    Poylin V; Fareed MU; O'Neal P; Alamdari N; Reilly N; Menconi M; Hasselgren PO
    Mediators Inflamm; 2008; 2008():317851. PubMed ID: 18389075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E; Alamdari N; Lecker SH; Hasselgren PO
    Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
    Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
    Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt.
    Gonçalves DA; Silveira WA; Lira EC; Graça FA; Paula-Gomes S; Zanon NM; Kettelhut IC; Navegantes LC
    Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E123-33. PubMed ID: 21952035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental hyperthyroidism in rats increases the expression of the ubiquitin ligases atrogin-1 and MuRF1 and stimulates multiple proteolytic pathways in skeletal muscle.
    O'Neal P; Alamdari N; Smith I; Poylin V; Menconi M; Hasselgren PO
    J Cell Biochem; 2009 Nov; 108(4):963-73. PubMed ID: 19777444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sepsis stimulates calpain activity in skeletal muscle by decreasing calpastatin activity but does not activate caspase-3.
    Wei W; Fareed MU; Evenson A; Menconi MJ; Yang H; Petkova V; Hasselgren PO
    Am J Physiol Regul Integr Comp Physiol; 2005 Mar; 288(3):R580-90. PubMed ID: 15563579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle.
    Wray CJ; Mammen JM; Hershko DD; Hasselgren PO
    Int J Biochem Cell Biol; 2003 May; 35(5):698-705. PubMed ID: 12672461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
    Baehr LM; Furlow JD; Bodine SC
    J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis.
    Krawiec BJ; Frost RA; Vary TC; Jefferson LS; Lang CH
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E969-80. PubMed ID: 16046454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of proteasome activity in muscle RING finger 1-null mice following denervation.
    Gomes AV; Waddell DS; Siu R; Stein M; Dewey S; Furlow JD; Bodine SC
    FASEB J; 2012 Jul; 26(7):2986-99. PubMed ID: 22508689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short-term cold exposure on skeletal muscle protein breakdown in rats.
    Manfredi LH; Zanon NM; Garófalo MA; Navegantes LC; Kettelhut IC
    J Appl Physiol (1985); 2013 Nov; 115(10):1496-505. PubMed ID: 23908317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis and glucocorticoids downregulate the expression of the nuclear cofactor PGC-1beta in skeletal muscle.
    Menconi MJ; Arany ZP; Alamdari N; Aversa Z; Gonnella P; O'Neal P; Smith IJ; Tizio S; Hasselgren PO
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E533-43. PubMed ID: 20647557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
    Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P38α-MAPK Signaling Inhibition Attenuates Soleus Atrophy during Early Stages of Muscle Unloading.
    Belova SP; Mochalova EP; Kostrominova TY; Shenkman BS; Nemirovskaya TL
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
    Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
    Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
    Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
    Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Branched-chain amino acids reduce hindlimb suspension-induced muscle atrophy and protein levels of atrogin-1 and MuRF1 in rats.
    Maki T; Yamamoto D; Nakanishi S; Iida K; Iguchi G; Takahashi Y; Kaji H; Chihara K; Okimura Y
    Nutr Res; 2012 Sep; 32(9):676-83. PubMed ID: 23084640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.
    Bodine SC; Baehr LM
    Am J Physiol Endocrinol Metab; 2014 Sep; 307(6):E469-84. PubMed ID: 25096180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gene expression and activity of calpains and the muscle wasting-associated ubiquitin ligases, atrogin-1 and MuRF1, are not altered in patients with primary hyperparathyroidism.
    Evenson A; Mitchell J; Wei W; Poylin V; Parangi S; Hasselgren PO
    Int J Mol Med; 2006 Sep; 18(3):471-5. PubMed ID: 16865232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.